Gene · 5499
Papers4,146
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,146
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants. | Emerg Microbes Infect | 2023 | 37555275 | PubTator, text mining | PubMed |
| Spatially resolved protein map of intact human cytomegalovirus virions. | Nat Microbiol | 2023 | 37550507 | PubTator, text mining | PubMed |
| Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors. | ACS Omega | 2023 | 37546609 | PubTator, text mining | PubMed |
| Inhibition by components of Glycyrrhiza uralensis of 3CLpro and HCoV-OC43 proliferation. | J Enzyme Inhib Med Chem | 2023 | 37537881 | PubTator, text mining | PubMed |
| Porcine epidemic diarrhea virus: an update overview of virus epidemiology, vaccines, and control strategies in South Korea. | J Vet Sci | 2023 | 37532301 | PubTator, text mining | PubMed |
| SARS-CoV-2 main protease targeting potent fluorescent inhibitors: Repurposing thioxanthones. | Turk J Chem | 2023 | 37528926 | PubTator, text mining | PubMed |
| SNHG15 aids SARS-CoV-2 entry via RABL2A. | RNA Biol | 2023 | 37528621 | PubTator, text mining | PubMed |
| A novel strategy to attenuate porcine reproductive and respiratory syndrome virus by inhibiting viral replication in the target pulmonary alveolar macrophages via hematopoietic-specific miR-142. | One Health Adv | 2023 | 37521530 | PubTator, text mining | PubMed |
| Astragaloside IV Regulates cGAS-STING Signaling Pathway to Alleviate Immunosuppression Caused by PRRSV Infection. | Viruses | 2023 | 37515271 | PubTator, text mining | PubMed |
| In Silico Substrate-Binding Profiling for SARS-CoV-2 Main Protease (Mpro) Using Hexapeptide Substrates. | Viruses | 2023 | 37515167 | PubTator, text mining | PubMed |
| Ebselen and Diphenyl Diselenide Inhibit SARS-CoV-2 Replication at Non-Toxic Concentrations to Human Cell Lines. | Vaccines (Basel) | 2023 | 37515038 | PubTator, text mining | PubMed |
| Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library. | Int J Mol Sci | 2023 | 37511149 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics for Unlocking Personalized Cancer Immunotherapy: Toward Targeting the Origin of Tumor Development Immunogenicity. | Cancers (Basel) | 2023 | 37509276 | PubTator, text mining | PubMed |
| Exploring the Immunomodulatory Properties of Stem Cells in Combating COVID-19: Can We Expect More? | Bioengineering (Basel) | 2023 | 37508830 | PubTator, text mining | PubMed |
| Research Progress on Porcine Reproductive and Respiratory Syndrome Virus NSP7 Protein. | Animals (Basel) | 2023 | 37508047 | PubTator, text mining | PubMed |
| Correlation between Hepatocyte Growth Factor (HGF) with D-Dimer and Interleukin-6 as Prognostic Markers of Coagulation and Inflammation in Long COVID-19 Survivors. | Curr Issues Mol Biol | 2023 | 37504277 | PubTator, text mining | PubMed |
| ORC1 binds to cis-transcribed RNAs for efficient activation of replication origins. | Nat Commun | 2023 | 37488096 | PubTator, text mining | PubMed |
| Isolation, identification, and pathogenicity of a NADC30-like porcine reproductive and respiratory disorder syndrome virus strain affecting sow production. | Front Vet Sci | 2023 | 37483283 | PubTator, text mining | PubMed |
| Systems pharmacology dissection of pharmacological mechanisms of Xiaochaihu decoction against human coronavirus. | BMC Complement Med Ther | 2023 | 37475019 | PubTator, text mining | PubMed |
| Exploring biomarkers of premature ovarian insufficiency based on oxford nanopore transcriptional profile and machine learning. | Sci Rep | 2023 | 37460774 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5499/papers?page=11